Automated, Transferable, and Ethanol-Free Radiosynthesis of [<sup>11</sup>C]Butanol
Cerebral blood flow and blood-brain barrier permeability assessment are crucial hemodynamic parameters to measure under neurological conditions. In conjunction with positron emission tomography (PET), oxygen-15-labeled water has emerged as a gold standard for measuring cerebral perfusion; however, at higher flow rates, [<sup>15</sup>O]water extraction becomes nonlinear. In such a scenario, freely diffusible [<sup>11</sup>C]butanol can provide a truer estimate. Radiosyntheses of [<sup>11</sup>C]butanol reported to date are protracted, are not automated, or require ethanol in the final formulation. By using a flow-based, captive solvent approach on a commercially available radiosynthesizer, we automated and reduced the synthesis time to 28 min. Forgoing cartridge-based purification for an aqueous high-performance liquid chromatography method, we obtained high purity [<sup>11</sup>C]butanol in ethanol-free phosphate buffered saline in sufficient yields for clinical PET studies. We here report our expedited, automated, and ethanol-free radiosynthesis of [<sup>11</sup>C]butanol along with preliminary imaging of a porcine subject.
Authors
- Udunna Anazodo (ORCID: https://orcid.org/0000-0001-8864-035X)
- Michael S. Kovacs (ORCID: https://orcid.org/0000-0003-0123-1356)
- Paulien Moyaert
- Olujide Oyeniran
- Justin W. Hicks (ORCID: https://orcid.org/0000-0003-0269-9364)
- Confidence Raymond (ORCID: https://orcid.org/0000-0003-3927-9697)
- Linshan Liu (ORCID: https://orcid.org/0000-0003-1203-0031)
Institutions
- Western University (CA)
- Montreal Neurological Institute and Hospital (CA)
- Lawson Health Research Institute (CA)
- Ghent University (BE)
- McGill University (CA)
Publication Details
- Journal
- ACS Chemical Neuroscience
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1021/acschemneuro.4c00455
- Citations
- 1
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- EU Joint Programme – Neurodegenerative Disease Research